Eon Generic Wellbutrin SR Injunction Vacated
This article was originally published in The Pink Sheet Daily
Eon no longer has the threat of a preliminary injunction hanging over its Wellbutrin SR generic (bupropion sustained-release)
You may also be interested in...
The 150 mg Impax/Teva product is following Eon's and Watson's 100 mg generics to the market. Andrx will receive a share of the profits.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."